Insider Trading & Ownership of Gary A. Lyons

Location: San Diego, CA
Summary: The estimated net worth of Gary A. Lyons is at least $20,245,398 dollars as of 04 Dec 2025. Gary A. Lyons is the Director of NEUROCRINE BIOSCIENCES INC and owns shares of NEUROCRINE BIOSCIENCES INC (NBIX) stock worth about $18.39M. Gary A. Lyons is the Director of Travere Therapeutics, Inc. and owns shares of Travere Therapeutics, Inc. (TVTX) stock worth about $1.05M. Gary A. Lyons is the Director of Eledon Pharmaceuticals, Inc. and owns shares of Eledon Pharmaceuticals, Inc. (ELDN) stock worth about $674K. Gary A. Lyons is the Director of RIGEL PHARMACEUTICALS INC and owns shares of RIGEL PHARMACEUTICALS INC (RIGL) stock worth about $131.2K.
Signature: /s/ Darin Lippoldt, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Gary A. Lyons files a new Insider Trading report.

Ownership of Gary A. Lyons

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
NBIX	NEUROCRINE BIOSCIENCES INC	Director	$18,386,215	-$2,289,083	-11%	03 Dec 2025
TVTX	Travere Therapeutics, Inc.	Director	$1,053,975			15 May 2025
ELDN	Eledon Pharmaceuticals, Inc.	Director	$673,958			01 May 2023
RIGL	RIGEL PHARMACEUTICALS INC	Director	$131,250			26 May 2023
FRTX	Brickell Biotech, Inc.	Director				17 May 2022

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.